Purpose
Interstitial cystitis/painful bladder syndrome (IC/PBS) is a devastating disease that is associated with multiple symptoms, and is usually diagnosed on the basis of pain, urgency and frequency in the absence of other known causes. To date there is no diagnostic test.
Methods
In vivo diagnostic contrast-enhanced magnetic resonance imaging (CE-MRI) was used, involving intravesical administration of Gd-DTPA (gadolinium diethylene triamine penta acetic acid) contrast via a catheter, for visualization of increased permeability of the bladder urothelium, and i.v. administration of Gd-DTPA was used to visualize secondary tissue effects to the colon, in a rat model undergoing intravesical exposure to protamine sulfate (PS).
Results
Both bladder urothelilium and colonic mucosa were assessed 24 hours following bladder PS exposure. Enhanced contrast MR images were able to establish bladder urothelium leakage of Gd-DTPA (399.7±68.7 % change in MRI signal intensity (SI) for PS-exposed rats, compared to 39.2±12.2 for controls; p<0.0001), and colonic-related uptake in contrast agent (65.2±17.1 % for PS-exposed rats, compared to 20.8±9.8 for controls; p<0.01) following bladder PS exposure. Kinetics of Gd-DTPA uptake and excretion were also obtained over 20 min in the bladder, and over 30 min in the colon, indicating increased signal intensities at 7 and 12 min, respectively.
Conclusions
These preliminary studies indicate that CE-MRI is capable of monitoring primary bladder urothelium loss of impermeability and secondary enhanced contrast in colon mucosa. This method can be considered a potential clinical diagnostic method for IC/PBS that involves loss of the permeability barrier, and assessing visceral organ cross-talk.